Tasmar Prices, Coupons, Copay Cards & Patient Assistance
Tasmar (tolcapone) is a member of the dopaminergic antiparkinsonism agents drug class and is commonly used for Parkinson's Disease.
The cost for Tasmar 100 mg oral tablet is around $11,243 for a supply of 90 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
A generic version of Tasmar is available. See tolcapone prices (from $4,025.83 for 90 tablets).
Tasmar prices
Oral Tablet
100 mg
Tasmar oral tablet
from $11,243.40
for 90 tablets
Quantity | Per unit | Price |
---|---|---|
90 | $124.93 | $11,243.40 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tasmar Coupons, Copay Cards and Rebates
Tasmar offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
No manufacturer promotions could be found for this medication.
Patient Assistance & Copay Programs for Tasmar
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Tasmar (tolcapone) Tablet
More information please phone: 866-316-7263 Visit Website
Provider: Bausch Health Patient Assistance Program
Eligibility requirements:- Must have no prescription coverage for needed medication
- Based on FPL
- FDA-approved diagnosis
- Must be a US resident and treated by a US licensed healthcare provider
- Hardship appeals for patients residing in Puerto Rico will be reviewed on a case-by-case basis. Call for information on the most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Tasmar (tolcapone) Tablet
More information please phone: 833-862-8727 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Tasmar (tolcapone)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español